| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |